Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Nov 19;62(21):1977-1985.
doi: 10.1016/j.jacc.2013.07.027. Epub 2013 Aug 7.

Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients

Affiliations
Free article
Comment

Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients

Jan-Christian Reil et al. J Am Coll Cardiol. .
Free article

Abstract

Objectives: The study aimed to determine whether isolated heart rate (HR) reduction with ivabradine reduces afterload of patients with systolic heart failure.

Background: The effective arterial elastance (Ea) represents resistive and pulsatile afterload of the heart derived from the pressure volume relation. HR modulates Ea, and, therefore, afterload burden.

Methods: Among the patients with systolic heart failure (ejection fraction ≤35%) randomized to either placebo or ivabradine in the SHIFT (Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial), 275 patients (n = 132, placebo; n = 143, ivabradine 7.5 mg twice a day) were included in the echocardiographic substudy. Ea, total arterial compliance (TAC), and end-systolic elastance (Ees) were calculated at baseline and after 8 months of treatment. Blood pressure was measured by arm cuff; stroke volume (SV), ejection fraction, and end-diastolic volume were assessed by echocardiography.

Results: At baseline Ea, TAC, HR, and Ees did not differ significantly between ivabradine- and placebo-treated patients. After 8 months of treatment, HR was significantly reduced in the ivabradine group (p < 0.0001) and was accompanied by marked reduction in Ea (p < 0.0001) and improved TAC (p = 0.004) compared with placebo. Although contractility remained unchanged, ventricular-arterial coupling was markedly improved (p = 0.002), resulting in a higher SV (p < 0.0001) in the ivabradine-treated patients.

Conclusions: Isolated HR reduction by ivabradine improves TAC, thus reducing Ea. Because Ees is unaltered, improved ventricular-arterial coupling is responsible for increased SV. Therefore, unloading of the heart may contribute to the beneficial effect of isolated HR reduction in patients with systolic heart failure.

Keywords: CO; EDV; EF; ESPVR; Ea; Ees; HF; HR; LV; LVOT; MAP; PP; PV; Pes; SV; TAC; TPR; cardiac output; effective arterial elastance; ejection fraction; end-diastolic volume; end-systolic elastance; end-systolic pressure; end-systolic pressure–volume relationship; heart failure; heart rate; heart rate reduction; left ventricular; left ventricular outflow tract; mean arterial pressure; pressure-volume; pulse pressure; stroke volume; systolic heart failure; total arterial compliance; total peripheral resistance; ventricular-arterial coupling.

PubMed Disclaimer

Comment on

MeSH terms

Substances

Associated data